Literature DB >> 26617910

Association between interleukin-10 gene promoter polymorphisms and susceptibility to liver cirrhosis.

Lanjie Yao1, Shuli Xing2, Xueqin Fu1, Hongjie Song1, Zhendong Wang1, Jianrong Tang1, Yongjing Zhao3.   

Abstract

We conducted a case-control study to investigate the association between three common SNPs in IL-10 gene (rs1800896, rs1800871 and rs1800872) and the development of liver cirrhosis in a Chinese population. Between January 2013 and December 2014, a total of 318 patients with liver cirrhosis and 318 health control subjects were enrolled into our study. The IL-10 rs1800896, rs1800871 and rs1800872 polymorphisms were analyzed using polymerase chain reaction (PCR) coupled with restriction fragment length polymorphism (RFLP). By multivariate logistic regression analysis, we found that individuals with the AA genotype and GA+AA genotype of IL-10 rs1800896 were more likely to have an increased risk of liver cirrhosis when compared with the GG genotype, and the ORs (95% CI) for the AA genotype and GA+AA genotype were 2.04 (1.20-3.50) and 1.41 (1.02-1.96), respectively. We found that the GA+AA genotype of IL-10 rs1800896 had higher risk of liver cirrhosis in individuals with chronic hepatitis B when compared with the GG genotype (OR = 1.95, 95% CI = 1.01-3.59). In conclusion, we found that IL-10 rs1800896 polymorphism was correlated with an increased risk of liver cirrhosis, especially in individuals with chronic hepatitis B.

Entities:  

Keywords:  Interleukin-10; liver cirrhosis; polymorphism

Mesh:

Substances:

Year:  2015        PMID: 26617910      PMCID: PMC4637726     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  21 in total

1.  [Association of IL-10-1082 and IL-10-592 polymorphisms with chronic hepatitis B and/or hepatitis C virus infection among plasma donors in a rural area of Hebei Province, China].

Authors:  Qiuju Gao; Shiyong Zhang; Lihong Wu; Min Jia; Yu Mi; Dianwu Liu
Journal:  Wei Sheng Yan Jiu       Date:  2011-11

2.  A -819 C/T polymorphism in the interleukin-10 promoter is associated with persistent HBV infection, but -1082 A/G and -592A/C polymorphisms are not: a meta-analysis.

Authors:  Hong Ren; Ting-Ting Zhang; Wen-Long Hu
Journal:  Arch Virol       Date:  2015-01-14       Impact factor: 2.574

3.  Association of Interleukin-1β and Gene Polymorphisms with Liver Pathogenesis in Hepatitis B Virus Infection among Eastern Indian Population.

Authors:  Avik Biswas; Rajesh Panigrahi; Manisha Pal; Binay K De; Sekhar Chakrabarti; Mrinmoy K Ghosh; Bikash C Chandra Seth; Susanta Roychowdhury; Runu Chakravarty
Journal:  J Clin Exp Hepatol       Date:  2013-12-04

4.  Influence of IL10 gene polymorphisms on the severity of liver fibrosis and susceptibility to liver cirrhosis in HBV/HCV-infected patients.

Authors:  Peng-Fei Guo; Juan Jin; Xiangru Sun
Journal:  Infect Genet Evol       Date:  2014-12-13       Impact factor: 3.342

5.  Hepatitis B virus infection.

Authors:  Yun-Fan Liaw; Chia-Ming Chu
Journal:  Lancet       Date:  2009-02-14       Impact factor: 79.321

6.  Hepatitis B virus Genotyping Among Patients With Cirrhosis.

Authors:  Nastaran Ansari; Manochehr Makvandi; Ali Reza Samarbaf-Zadeh
Journal:  Jundishapur J Microbiol       Date:  2015-01-14       Impact factor: 0.747

7.  Association of interleukin-10 with hepatitis B virus (HBV) mediated disease progression in Indian population.

Authors:  Roli Saxena; Yogesh Kumar Chawla; Indu Verma; Jyotdeep Kaur
Journal:  Indian J Med Res       Date:  2014-05       Impact factor: 2.375

8.  Interleukin-16 gene polymorphisms are considerable host genetic factors for patients' susceptibility to chronic hepatitis B infection.

Authors:  Sara Romani; Seyed Masoud Hosseini; Seyed Reza Mohebbi; Shabnam Kazemian; Shaghayegh Derakhshani; Mahsa Khanyaghma; Pedram Azimzadeh; Afsaneh Sharifian; Mohammad Reza Zali
Journal:  Hepat Res Treat       Date:  2014-11-26

9.  Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells.

Authors:  A D'Andrea; M Aste-Amezaga; N M Valiante; X Ma; M Kubin; G Trinchieri
Journal:  J Exp Med       Date:  1993-09-01       Impact factor: 14.307

10.  Role of interleukin-28B genetic polymorphisms in Korean patients with hepatitis C virus infection.

Authors:  Ho Kil; Sook-Hyang Jeong; Jin-Wook Kim; Young Sang Byoun; Bo Young Min; Byung-Hyun Woo; Youn Jae Lee; Young Seok Kim
Journal:  Gut Liver       Date:  2013-11-05       Impact factor: 4.519

View more
  4 in total

1.  Effect of entecavir in the treatment of patients with hepatitis B virus-related compensated and decompensated cirrhosis.

Authors:  Xiao-Dong Gai; Wei-Feng Wu
Journal:  Exp Ther Med       Date:  2017-08-18       Impact factor: 2.447

2.  Bone marrow-derived monocyte infusion improves hepatic fibrosis by decreasing osteopontin, TGF-β1, IL-13 and oxidative stress.

Authors:  Veruska Cintia Alexandrino de Souza; Thiago Almeida Pereira; Valéria Wanderley Teixeira; Helotonio Carvalho; Maria Carolina Accioly Brelaz de Castro; Carolline Guimarães D'assunção; Andréia Ferreira de Barros; Camila Lima Carvalho; Virgínia Maria Barros de Lorena; Vláudia Maria Assis Costa; Álvaro Aguiar Coelho Teixeira; Regina Celia Bressan Queiroz Figueiredo; Sheilla Andrade de Oliveira
Journal:  World J Gastroenterol       Date:  2017-07-28       Impact factor: 5.742

3.  Adoptive Transfer of Bone Marrow-Derived Monocytes Ameliorates Schistosoma mansoni -Induced Liver Fibrosis in Mice.

Authors:  Veruska Cintia Alexandrino de Souza; Danielle Maria Nascimento Moura; Maria Carolina Accioly Brelaz de Castro; Patrícia Torres Bozza; Ligia de Almeida Paiva; Camila Juliet Barbosa Fernandes; Renata Lins Carneiro Leão; Jéssica Paula Lucena; Roni Evencio de Araujo; Alex José de Melo Silva; Regina Celia Bressan Queiroz Figueiredo; Sheilla Andrade de Oliveira
Journal:  Sci Rep       Date:  2019-04-23       Impact factor: 4.379

4.  IL-6 and IL-10 gene polymorphisms and cirrhosis of liver risk from a comprehensive analysis.

Authors:  Minghui Zheng; Weizhen Fang; Menglei Yu; Rui Ding; Hua Zeng; Yan Huang; Yuanyang Mi; Chaohui Duan
Journal:  BMC Endocr Disord       Date:  2021-12-09       Impact factor: 2.763

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.